The Enrichment Program that is part of the University of Washington's Diabetes Research Center is well established and highly successful. Its goal is to help create an environment that supports novel and innovative research by promoting scientific exchange, collaboration, training and a broadening of research ideas relevant to diabetes, obesity and related disorders. The Enrichment Program continues to leverage the resources of the Diabetes Research Center together with those of other University of Washington centers including the Nutrition Obesity Research Center, University of Washington Diabetes Institute, and Cystic Fibrosis Research and Translation Center combined with two other Seattle institutions, namely Pacific Northwest Diabetes Research Institute and Benaroya Research Institute. The Program comprises the following components: (1) Seminar series, with lectures held at least twice per month during the academic year and including the annual Kroc Scholar Lecture; (2) Annual DRC-Nutrition Obesity Research Center (NORC) Research Retreat, featuring presentations by Pilot and Feasibility (P&F) awardees of both Centers, a visiting keynote speaker, local rising star speaker and a poster session for trainees; (3) Symposia, including the Annual Research Symposium and Poll Type 1 Diabetes and Immunology Symposium; (4) One-on-one meetings between affiliate investigators and their trainees with visiting seminar/symposium speakers; (5) Resources and opportunities to enhance training in diabetes research, including formal and informal venues for trainees to present their work and interact with local and visiting faculty and participation in the NIDDK Medical Student Research Program in Diabetes; and (6) Research Interest Groups, which meet frequently to foster informal interactions among DRC affiliates working in one of six topics that encompass the broad range of diabetes research undertaken at the University of Washington. Through these offerings, the Enrichment Program continues to serve its goal of fostering interaction and collaboration between Diabetes Research Center affiliate investigators and scientists from outside Seattle.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK017047-45
Application #
10077868
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2018-02-10
Project End
2022-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Houston, Denise K; Neiberg, Rebecca H; Miller, Michael E et al. (2018) Physical Function Following a Long-Term Lifestyle Intervention Among Middle Aged and Older Adults With Type 2 Diabetes: The Look AHEAD Study. J Gerontol A Biol Sci Med Sci 73:1552-1559
Guo, Rui; Hua, Yinan; Ren, Jun et al. (2018) Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity. Cell Death Dis 9:692
van Zuydam, Natalie R; Ahlqvist, Emma; Sandholm, Niina et al. (2018) A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes. Diabetes 67:1414-1427
Tanaka, Shigeru; Pfleger, Christian; Lai, Jen-Feng et al. (2018) KAP1 Regulates Regulatory T Cell Function and Proliferation in Both Foxp3-Dependent and -Independent Manners. Cell Rep 23:796-807
Koletzko, Sibylle; Lee, Hye-Seung; Beyerlein, Andreas et al. (2018) Cesarean Section on the Risk of Celiac Disease in the Offspring: The Teddy Study. J Pediatr Gastroenterol Nutr 66:417-424
Roe, Nathan D; Handzlik, Michal K; Li, Tao et al. (2018) The Role of Diacylglycerol Acyltransferase (DGAT) 1 and 2 in Cardiac Metabolism and Function. Sci Rep 8:4983
Chepurny, Oleg G; Bonaccorso, Ron L; Leech, Colin A et al. (2018) Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors. Sci Rep 8:3749
Hull, Rebecca L; Gibson, Ronald L; McNamara, Sharon et al. (2018) Islet Interleukin-1? Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to ?-Cell Failure. Diabetes Care 41:823-830
Kikuchi, Shinsuke; Chen, Lihua; Xiong, Kevin et al. (2018) Smooth muscle cells of human veins show an increased response to injury at valve sites. J Vasc Surg 67:1556-1570.e9
Erickson, Michelle A; Banks, William A (2018) Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions. Pharmacol Rev 70:278-314

Showing the most recent 10 out of 1296 publications